_version_ 1797617621278916608
author Евгения Алексеевна Созуракова
Елизавета Александровна Третьяк
Андрей Владимирович Шабалдин
Елизавета Евгеньевна Помешкина
Татьяна Валерьевна Радченко
Кира Борисовна Мозес
Елена Владимировна Рудаева
Светлана Ивановна Елгина
Наталья Степановна Черных
author_facet Евгения Алексеевна Созуракова
Елизавета Александровна Третьяк
Андрей Владимирович Шабалдин
Елизавета Евгеньевна Помешкина
Татьяна Валерьевна Радченко
Кира Борисовна Мозес
Елена Владимировна Рудаева
Светлана Ивановна Елгина
Наталья Степановна Черных
author_sort Евгения Алексеевна Созуракова
collection DOAJ
description Clinical results and some medical difficulties in ophthalmology is straight connected with repairing processes and unpredictable cellular response. The opportunity of enzyme medicine using is associated with their ability to raise the therapeutic effect in different pathological cases in clinical practice. Often because of fibrin extra production the result of the disease could be unfavourable. Searching for the treatment method which could prevent fibrin extra production is the actual ophthalmological problem. Longidaza is a conjugate of enzyme hyaluronidase with high molecular weight azoximer, and it has an opportunity to lyse extra fibrin fibres, which was produced during the inflammation process after traumatic damage, surgical treatment. The efficiency of the using of enzyme medicines is reported in cornea pathological cases, and in vitreous body pathological cases, that could be a new conservative way for treatment. The advantages of longidaza are: atraumatic injections ways; minimal side-effects; no rehabilitation period; low price. According to ambiguous in opinions it is necessary to continue to research Longidaza.
first_indexed 2024-03-11T07:58:27Z
format Article
id doaj.art-12e32b895b044adc860681bd533efc67
institution Directory Open Access Journal
issn 1819-0901
2588-0411
language Russian
last_indexed 2024-03-11T07:58:27Z
publishDate 2023-08-01
publisher The Publishing House Medicine and Enlightenment
record_format Article
series Medicina v Kuzbasse
spelling doaj.art-12e32b895b044adc860681bd533efc672023-11-17T02:46:56ZrusThe Publishing House Medicine and EnlightenmentMedicina v Kuzbasse1819-09012588-04112023-08-01223511823THE LONGIDAZA USING IN OPHTHALMOLOGYЕвгения Алексеевна Созуракова0Елизавета Александровна Третьяк1Андрей Владимирович Шабалдин2Елизавета Евгеньевна Помешкина3Татьяна Валерьевна Радченко4Кира Борисовна Мозес5Елена Владимировна Рудаева6Светлана Ивановна Елгина7Наталья Степановна Черных8ФГБОУ ВО КемГУ; ГАУЗ ККБ им. С.В. Беляева, г. КемеровоГАУЗ ККБ им. С.В. Беляева, г. КемеровоФГБОУ ВО КемГУ, г. КемеровоФГБОУ ВО КемГУ, г. КемеровоФГБОУ ВО КемГУ, г. КемеровоФГБОУ ВО КемГМУ Минздрава России, г. КемеровоФГБОУ ВО КемГМУ Минздрава России, г. КемеровоФГБОУ ВО КемГМУ Минздрава России, г. КемеровоФГБОУ ВО КемГМУ Минздрава России, г. КемеровоClinical results and some medical difficulties in ophthalmology is straight connected with repairing processes and unpredictable cellular response. The opportunity of enzyme medicine using is associated with their ability to raise the therapeutic effect in different pathological cases in clinical practice. Often because of fibrin extra production the result of the disease could be unfavourable. Searching for the treatment method which could prevent fibrin extra production is the actual ophthalmological problem. Longidaza is a conjugate of enzyme hyaluronidase with high molecular weight azoximer, and it has an opportunity to lyse extra fibrin fibres, which was produced during the inflammation process after traumatic damage, surgical treatment. The efficiency of the using of enzyme medicines is reported in cornea pathological cases, and in vitreous body pathological cases, that could be a new conservative way for treatment. The advantages of longidaza are: atraumatic injections ways; minimal side-effects; no rehabilitation period; low price. According to ambiguous in opinions it is necessary to continue to research Longidaza.https://mednauki.ru/index.php/MK/article/view/938лонгидазагиалуронидазаэнзимная терапияпролиферативный ответфибринолиз
spellingShingle Евгения Алексеевна Созуракова
Елизавета Александровна Третьяк
Андрей Владимирович Шабалдин
Елизавета Евгеньевна Помешкина
Татьяна Валерьевна Радченко
Кира Борисовна Мозес
Елена Владимировна Рудаева
Светлана Ивановна Елгина
Наталья Степановна Черных
THE LONGIDAZA USING IN OPHTHALMOLOGY
Medicina v Kuzbasse
лонгидаза
гиалуронидаза
энзимная терапия
пролиферативный ответ
фибринолиз
title THE LONGIDAZA USING IN OPHTHALMOLOGY
title_full THE LONGIDAZA USING IN OPHTHALMOLOGY
title_fullStr THE LONGIDAZA USING IN OPHTHALMOLOGY
title_full_unstemmed THE LONGIDAZA USING IN OPHTHALMOLOGY
title_short THE LONGIDAZA USING IN OPHTHALMOLOGY
title_sort longidaza using in ophthalmology
topic лонгидаза
гиалуронидаза
энзимная терапия
пролиферативный ответ
фибринолиз
url https://mednauki.ru/index.php/MK/article/view/938
work_keys_str_mv AT evgeniâalekseevnasozurakova thelongidazausinginophthalmology
AT elizavetaaleksandrovnatretʹâk thelongidazausinginophthalmology
AT andrejvladimirovičšabaldin thelongidazausinginophthalmology
AT elizavetaevgenʹevnapomeškina thelongidazausinginophthalmology
AT tatʹânavalerʹevnaradčenko thelongidazausinginophthalmology
AT kiraborisovnamozes thelongidazausinginophthalmology
AT elenavladimirovnarudaeva thelongidazausinginophthalmology
AT svetlanaivanovnaelgina thelongidazausinginophthalmology
AT natalʹâstepanovnačernyh thelongidazausinginophthalmology
AT evgeniâalekseevnasozurakova longidazausinginophthalmology
AT elizavetaaleksandrovnatretʹâk longidazausinginophthalmology
AT andrejvladimirovičšabaldin longidazausinginophthalmology
AT elizavetaevgenʹevnapomeškina longidazausinginophthalmology
AT tatʹânavalerʹevnaradčenko longidazausinginophthalmology
AT kiraborisovnamozes longidazausinginophthalmology
AT elenavladimirovnarudaeva longidazausinginophthalmology
AT svetlanaivanovnaelgina longidazausinginophthalmology
AT natalʹâstepanovnačernyh longidazausinginophthalmology